Contact us
Contact Us
Official channels for reporting adverse events and pharmacovigilance matters in: Barbados, Bolivia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Jamaica, Nicaragua, Panama, Paraguay, Peru, Trinidad & Tobago, and Uruguay.
Pharmacovigilance is a shared responsibility among healthcare professionals, patients, and all parties involved in the use of medicinal products. CSL Behring promotes the reporting of suspected adverse reactions and any safety-related issues associated with its products. If your inquiry relates to the reporting of an Adverse Event or Special Situations (including overdose, medication error, misuse, abuse, off-label use, lack of efficacy, therapeutic failure, absence of effect, unexpected beneficial effect, suspected transmission of infectious agents or exposure during pregnancy or breastfeeding), reports may be submitted through the form available below or to the email PhvPanama@cslbehring.com
Thank You
Your message has been sent
Data Privacy: The information you provide will be kept confidential. It will be processed and reported to health authorities to fulfill legal pharmacovigilance obligations. Our privacy notice is available at https://privacy.csl.com/pv-medinfo-pqc
Market Access & Marketing Information
Luis Fernando Aragon
Market Access & Marketing Manager - GLAD
E-mail: luis.aragon@cslbehring.com